(Q24187296)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26624881%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Pharmacotherapy for chronic cognitive impairment in traumatic brain injury (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26624881%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

main subject

brain

0 references

traumatic brain injury

0 references

pharmacotherapy

0 references

cognitive dysfunction

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26624881%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Dominic Dougall

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26624881%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Niruj Agrawal

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26624881%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

1 December 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26624881%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26624881%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26624881%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

CD009221

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26624881%20AND%20SRC:MED&resulttype=core&format=json

A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury.

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Placebo-controlled cross-over study of the monoaminergic stabiliser (-)-OSU6162 in mental fatigue following stroke or traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Atomoxetine for attention deficits following traumatic brain injury: results from a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Effects of rivastigmine on cognitive function in patients with traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Methylphenidate reduces mental fatigue and improves processing speed in persons suffered a traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

A double-blind controlled study of methylphenidate treatment in closed head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

A randomized controlled trial of rivastigmine for chronic sequels of traumatic brain injury-what it showed and taught?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Diffuse axonal injury in non-missile head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Attention and memory dysfunction after traumatic brain injury: cholinergic mechanisms, sensory gating, and a hypothesis for further investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Recovery from mild head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Wechsler Memory Scale performance and its relationship to brain damage after severe closed head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Postconcussional disorder: time to acknowledge a common source of neurobehavioral morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

II. In vitro evidence that (-)-OSU6162 and (+)-OSU6162 produce their behavioral effects through 5-HT2A serotonin and D2 dopamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

I. In vivo evidence for partial agonist effects of (-)-OSU6162 and (+)-OSU6162 on 5-HT2A serotonin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Bias in treatment assignment in controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Long term outcome after traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

MR imaging of head trauma: review of the distribution and radiopathologic features of traumatic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

A review of cholinergic agents in the treatment of neurobehavioral deficits following traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Longitudinal cognitive changes in traumatic brain injury: a 30-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Assessment of outcome after severe brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Axis I and II psychiatric disorders after traumatic brain injury: a 30-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Stimulating and inhibitory effects of the dopamine "stabilizer" (-)-OSU6162 on dopamine D2 receptor function in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Neurobehavioural deficits after severe traumatic brain injury (TBI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Randomized controlled trials in adult traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Working memory impairments in traumatic brain injury: evidence from a dual-task paradigm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Modafinil: a review of neurochemical actions and effects on cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

The agitated brain injured patient. Part 2: Pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Pharmacotherapy for chronic cognitive impairment in traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Dopamine and the origins of human intelligence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Cognitive rehabilitation for traumatic brain injury: A randomized trial. Defense and Veterans Head Injury Program (DVHIP) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Cognitive Sequelae and Recovery Course after Moderate and Severe Head Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Psychosocial consequences of stroke: a long-term population-based follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Disability in young people and adults one year after head injury: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Difference in neurotransmitter metabolism in frontotemporal-lobe contusion and diffuse cerebral contusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Functional outcomes in traumatic disorders of consciousness: 5-year outcomes from the National Institute on Disability and Rehabilitation Research Traumatic Brain Injury Model Systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Cholinomimetic agents and neurocognitive impairment following head injury: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009221.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/14651858.CD009221.PUB2

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26624881%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017